Mr. Mark Upsdell reports

RAPID DOSE ANNOUNCES PROPOSED ISSUANCE OF SHARES AS PAYMENT OF DIRECTOR FEES

Rapid Dose Therapeutics Corp. has agreed with its non-management directors to issue common shares to such directors in exchange for the cancellation of director fees owing. Each of the five directors is owed $10,000 in director fees for each of the fiscal quarters ended Feb. 28, 2025, and May 31, 2025, for an aggregate total amount of $100,000 owing to the directors. The debt shares to be issued in payment of the debt will be issued at a deemed price of 21 cents, being equivalent to the closing market price of the company's common shares on the Canadian Securities Exchange (the CSE) on June 27, 2025, in accordance with the policies of the CSE. The company expects to issue the debt shares no later than July 15, 2025.

The company is completing this shares for debt transaction to improve its financial position by reducing its existing liabilities. All debt shares issued will be subject to a four-month hold period from the date of issuance, as applicable. No new control person of the company is expected to be created pursuant to this transaction.

The issuance of the debt shares will be a related party transaction within the meaning of Multilateral Instrument 61-101 (MI 61-101). The company will be relying on the exemptions from the valuation and minority shareholder approval requirements of MI 61-101 contained in Section 5.5(b) (company is listed on the Canadian Securities Exchange) and Section 5.7(1)(a) (fair market value of the transaction insofar as it involves related parties does not exceed 25 per cent of the company's market capitalization) in respect of such transaction. A resolution of the board of directors of the company was passed to approve this shares for debt transaction. There was no materially contrary view by any director.

About Rapid Dose Therapeutics Corp.

Rapid Dose Therapeutics is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient.

We seek Safe Harbor.